anmelden
BX Swiss TOP 30 CHF
1.465,58
PKT
+3,82
PKT
+0,26
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 13.01.25 | Richemont Buy | UBS AG | |
| 13.01.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 13.01.25 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 10.01.25 | Swiss Re Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.01.25 | Richemont Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.01.25 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 10.01.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 09.01.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 09.01.25 | Richemont Sector Perform | RBC Capital Markets | |
| 08.01.25 | Nestlé Market-Perform | Bernstein Research | |
| 08.01.25 | UBS Hold | Deutsche Bank AG | |
| 08.01.25 | Nestlé Underperform | Jefferies & Company Inc. | |
| 07.01.25 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 07.01.25 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.01.25 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.01.25 | Swiss Re Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.01.25 | Roche Outperform | Bernstein Research | |
| 07.01.25 | Novartis Outperform | Bernstein Research | |
| 06.01.25 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 06.01.25 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 06.01.25 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 06.01.25 | UBS Outperform | RBC Capital Markets | |
| 06.01.25 | Givaudan Neutral | UBS AG | |
| 06.01.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 06.01.25 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 06.01.25 | ABB (Asea Brown Boveri) Underperform | Bernstein Research | |
| 03.01.25 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 02.01.25 | Richemont Buy | UBS AG | |
| 30.12.24 | Nestlé Market-Perform | Bernstein Research | |
| 27.12.24 | UBS Outperform | RBC Capital Markets | |
| 27.12.24 | Nestlé Market-Perform | Bernstein Research | |
| 19.12.24 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 19.12.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 19.12.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 19.12.24 | Zurich Insurance Sell | UBS AG | |
| 19.12.24 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
| 18.12.24 | Givaudan Hold | Deutsche Bank AG | |
| 18.12.24 | Givaudan Neutral | UBS AG | |
| 18.12.24 | Givaudan Buy | Goldman Sachs Group Inc. | |
| 17.12.24 | Novartis Hold | Deutsche Bank AG |
